WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Can chatbots help with genetic testing for cancer risk?

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a
Oncology September 27,2024
Can chatbots help with genetic testing for cancer risk?

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a
Oncology September 27,2024
Sweden sees skin cancer decline in under-50s for 1st time: Study

Sweden sees skin cancer decline in under-50s for 1st time: Study

Credit: Anna Tarazevich from PexelsSkin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researcher
Dermatology September 27,2024
Sweden sees skin cancer decline in under-50s for 1st time: Study

Sweden sees skin cancer decline in under-50s for 1st time: Study

Credit: Anna Tarazevich from PexelsSkin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researcher
Dermatology September 27,2024
New study explores challenges and opportunities for cancer research

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the
Oncology September 25,2024
New study explores challenges and opportunities for cancer research

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the
Oncology September 25,2024
Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe
Dermatology September 25,2024
Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe
Dermatology September 25,2024
Study reveals how insulin-producing cells work together to respond to metabolic demands

Study reveals how insulin-producing cells work together to respond to metabolic demands

by Emily Packer, George Litchfield,eLifeModulation of individual IPCs by aminergic and peptidergic neurons in patch-clamp recordings. Credit:eLife(2024). DOI: 10.7554/eLife.99548.1Sc
Diabetes & Endocrinology September 25,2024
Study reveals how insulin-producing cells work together to respond to metabolic demands

Study reveals how insulin-producing cells work together to respond to metabolic demands

by Emily Packer, George Litchfield,eLifeModulation of individual IPCs by aminergic and peptidergic neurons in patch-clamp recordings. Credit:eLife(2024). DOI: 10.7554/eLife.99548.1Sc
Diabetes & Endocrinology September 25,2024
New study shows that chronic neurodegeneration can be prevented after traumatic brain injury

New study shows that chronic neurodegeneration can be prevented after traumatic brain injury

byUniversity Hospitals Cleveland Medical CenterGraphical abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101715Violent blows or jolts to the head can cause tra
Neurology September 25,2024
New study shows that chronic neurodegeneration can be prevented after traumatic brain injury

New study shows that chronic neurodegeneration can be prevented after traumatic brain injury

byUniversity Hospitals Cleveland Medical CenterGraphical abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101715Violent blows or jolts to the head can cause tra
Neurology September 25,2024
Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC

Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainA Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-s
Pulmonology September 25,2024
Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC

Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainA Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-s
Pulmonology September 25,2024
Researchers identify cellular pathways whose dysregulation leads to acne lesions

Researchers identify cellular pathways whose dysregulation leads to acne lesions

byUniversity of California, Los AngelesA schematic overview highlighting the critical role of GRN in promoting inflammatory responses in TREM2 macrophages and IL-13RA1 in modulating the expressi
Dermatology September 25,2024
Researchers identify cellular pathways whose dysregulation leads to acne lesions

Researchers identify cellular pathways whose dysregulation leads to acne lesions

byUniversity of California, Los AngelesA schematic overview highlighting the critical role of GRN in promoting inflammatory responses in TREM2 macrophages and IL-13RA1 in modulating the expressi
Dermatology September 25,2024
Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancerby International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe
Pulmonology September 25,2024
Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancer

Taletrectinib shows clinically meaningful response and favorable safety in ROS1+ non-small cell lung cancerby International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe
Pulmonology September 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com